Novogenia AG (MUN:7V0)

Germany · Delayed Price · Currency is EUR

7.05

0.00 (0.00%)

Last updated: Jul 15, 2026, 8:00 AM CET

-3.42% (1Y)

Market Cap	84.60M -29.5%
Revenue (ttm)	54.30M -59.2%
Net Income	545.47K -97.7%
EPS	0.05 -97.7%
Shares Out	12.00M
PE Ratio	155.10
Forward PE	n/a
Dividend	0.56 (7.98%)
Ex-Dividend Date	Jun 29, 2026

Volume	n/a
Open	7.05
Previous Close	7.05
Day's Range	7.05 - 7.05
52-Week Range	5.70 - 11.80
Beta	0.33
Analysts	Strong Buy
Price Target	19.38 (+174.89%)
Earnings Date	Sep 8, 2026

About Novogenia AG

Novogenia AG operates in the healthcare industry. The company offers dietary supplements and cosmetics products. It also provides consulting and support services. The company was formerly known as Darwin AG and changed its name to Novogenia AG in June 2026. The company was incorporated in 2021 and is based in Munich, Germany. [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2021

Employees 204

Stock Exchange Munich Stock Exchange

Ticker Symbol 7V0

Full Company Profile

Financial Performance

In 2025, Novogenia AG's revenue was 54.30 million, an increase of 98.53% compared to the previous year's 27.35 million. Earnings were 545,469, a decrease of -97.04%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 7V0 stock is "Strong Buy." The 12-month stock price target is €19.38, which is an increase of 174.89% from the latest price.

Price Target

€19.38

(174.89% upside)

Analyst Consensus: Strong Buy

Stock Forecasts